Umbilical cord blood stem cells for myocardial repair and regeneration

Methods in Molecular Biology

Volumn 660, Issue , 2010, Pages 29-52

  Greco, Nicholas ^a   Laughlin, Mary J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow; Paracrine; Regenerative; Revascularization; Umbilical cord blood

Indexed keywords

EID: 84934437109     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-705-1_3     Document Type: Article

References (81)

1. Watkins, L. O. (2004) Epidemiology and burden of cardiovascular disease. Clin Cardiol 27, III2-6.
2. Libby, P., Theroux, P. (2005) Pathophysiology of coronary artery disease. Circulation 111, 3481-8.
3. Rubinstein, P., Carrier, C., Scaradavou, A., et al. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339, 1565-77.
4. Kurtzberg, J. (1996) Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation. J Hematother 5, 95-6.
5. Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLAidentical sibling. N Engl J Med 321, 1174-8.
6. Tse, W. W., Zang, S. L., Bunting, K. D., Laughlin, M. J. (2008) Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplant 41, 465-72.
7. Laughlin, M. J., Barker, J., Bambach, B., et al. (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344, 1815-22.
8. Laughlin, M. J., Eapen, M., Rubinstein, P., et al. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351, 2265-75.
9. Atsuta, Y., Suzuki, R., Nagamura-Inoue, T., et al. (2009) Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 113, 1631-8.
10. Appelbaum, F. R. (2008) Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available Hematology Am Soc Hematol Educ Program 2008, 412-7.
11. Wall, D. A., Chan, K. W. (2008) Selection of cord blood unit(s) for transplantation. Bone Marrow Transplant 42, 1-7.
12. MacMillan, M. L., Davies, S. M., Nelson, G. O., et al. (2008) Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 14, 16-22.
13. Jaing, T. H., Hung, I. J., Yang, C. P., Tsai, M. H., Lee, W. I., Sun, C. F. (2008) Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia. Pediatr Transplant 13(6):766-8.
14. Gluckman, E., Wagner, J. E. (2008) Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 41, 127-32.
15. Tepper, O. M., Capla, J. M., Galiano, R. D., et al. (2005) Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrowderived cells. Blood 105, 1068-77.
16. Assmus, B., Honold, J., Schachinger, V., et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355, 1222-32.
17. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355, 1210-21.
18. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006) Improved clinical outcome after intracoronary administration of bone-marrowderived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIRAMI trial. Eur Heart J 27, 2775-83.
19. Schachinger, V., Tonn, T., Dimmeler, S., Zeiher, A. M. (2006) Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 3 (Suppl 1), S23-8.
20. Lunde, K., Solheim, S., Aakhus, S., et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355, 1199-209.
21. Dzau, V. J., Gnecchi, M., Pachori, A. S., Morello, F., Melo, L. G. (2005) Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46, 7-18.
22. Gnecchi, M., He, H., Noiseux, N., et al. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20, 661-9.
23. Kucia, M., Reca, R., Campbell, F. R., et al. (2006) A population of very small embryoniclike (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20, 857-69.
24. Aiuti, A., Turchetto, L., Cota, M., et al. (1999) Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 94, 62-73.
25. Kucia, M., Dawn, B., Hunt, G., et al. (2004) Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95, 1191-9.
26. Massa, M., Rosti, V., Ferrario, M., et al. (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105, 199-206.
27. Jo, D. Y., Rafii, S., Hamada, T., Moore, M. A. (2000) Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest 105, 101-11.
28. Askari, A. T., Unzek, S., Popovic, Z. B., et al. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703.
29. Kogler, G., Sensken, S., Airey, J. A., et al. (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200, 123-35.
30. Kim, B. O., Tian, H., Prasongsukarn, K., et al. (2005) Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted 50 Greco and Laughlin somatic stem cells in a porcine model. Circulation 112, I96-104.
31. Bonanno, G., Perillo, A., Rutella, S., et al. (2004) Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion 44, 1087-97.
32. Civin, C. I., Almeida-Porada, G., Lee, M. J., Olweus, J., Terstappen, L. W., Zanjani, E. D. (1996) Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 88, 4102-9.
33. Civin, C. I., Trischmann, T., Kadan, N. S., et al. (1996) Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 14, 2224-33.
34. Fina, L., Molgaard, H. V., Robertson, D., et al. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75, 2417-26.
35. Peichev, M., Naiyer, A. J., Pereira, D., et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95, 952-8.
36. Fedak, P. W. (2008) Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart. Semin Thorac Cardiovasc Surg 20, 87-93.
37. Chauhan, A., More, R. S., Mullins, P. A., Taylor, G., Petch, C., Schofield, P. M. (1996) Aging-associated endothelial dysfunction in humans is reversed by l-arginine. J Am Coll Cardiol 28, 1796-804.
38. Tschudi, M. R., Barton, M., Bersinger, N. A., et al. (1996) Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98, 899-905.
39. Urbich, C., Aicher, A., Heeschen, C., et al. (2005) Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39, 733-42.
40. Tang, Y. L., Tang, Y., Zhang, Y. C., Qian, K., Shen, L., Phillips, M. I. (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46, 1339-50.
41. Ikeda, Y., Fukuda, N., Wada, M., et al. (2004) Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res 27, 119-28.
42. Frangogiannis, N. G. (2004) Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53, 585-95.
43. Frangogiannis, N. G. (2004) The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol 2, 163-74.
44. Real, C., Caiado, F., Dias, S. (2008) Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do? Cardiovasc Hematol Disord Drug Targets 8, 185-93.
45. Kinnaird, T., Stabile, E., Epstein, S. E., Fuchs, S. (2003) Current perspectives in therapeutic myocardial angiogenesis. J Interv Cardiol 16, 289-97.
46. Walter, D. H., Haendeler, J., Reinhold, J., et al. (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97, 1142-51.
47. Pinhal-Enfield, G., Ramanathan, M., Hasko, G., et al. (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163, 711-21.
48. Koczulla, R., Degenfeld, G., Kupatt, C., et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111, 1665-72.
49. Matzinger, P. (2002) The danger model: a renewed sense of self. Science 296, 301-5.
50. Fu, J., Lin, G., Zeng, B., et al. (2006) Antiischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity. Biochem Biophys Res Commun 350, 162-8.
51. Mahaffey, K. W., Granger, C. B., Nicolau, J. C., et al. (2003) Effect of pexelizumab, an anti- C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation 108, 1176-83.
52. Litt, M. R., Jeremy, R. W., Weisman, H. F., Winkelstein, J. A., Becker, L. C. (1989) Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophilmediated reperfusion injury. Circulation 80, 1816-27.
53. Solomon, D. H., Schneeweiss, S., Glynn, R. J., et al. (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109, 2068-73.
54. Weihrauch, D., Arras, M., Zimmermann, R., Schaper, J. (1995) Importance of monocytes/macrophages and fibroblasts for healing of Umbilical Cord Blood Stem Cells for Myocardial Repair and Regeneration 51 micronecroses in porcine myocardium. Mol Cell Biochem 147, 13-9.
55. Wu, K. H., Zhou, B., Mo, X. M., et al. (2007) Therapeutic potential of human umbilical cord-derived stem cells in ischemic diseases. Transplant Proc 39, 1620-2.
56. Henning, R. J., Burgos, J. D., Ondrovic, L., Sanberg, P., Balis, J., Morgan, M. B. (2006) Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 15, 647-58.
57. Elmadbouh, I., Haider, H., Jiang, S., Idris, N. M., Lu, G., Ashraf, M. (2007) Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42, 792-803.
58. Smith, R. R., Barile, L., Messina, E., Marban, E. (2008) Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm 5, 880-7.
59. Gepstein, L. (2008) Electrophysiologic implications of myocardial stem cell therapies. Heart Rhythm 5, S48-52.
60. Mihu, C. M., Mihu, D., Costin, N., Rus Ciuca, D., Susman, S., Ciortea, R. (2008) Isolation and characterization of stem cells from the placenta and the umbilical cord. Rom J Morphol Embryol 49, 441-6.
61. Martins, A. A., Paiva, A., Morgado, J. M., Gomes, A., Pais, M. L. (2009) Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc 41, 943-6.
62. Chamberlain, G., Fox, J., Ashton, B., Middleton, J. (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739-49.
63. Yamada, Y., Yokoyama, S., Wang, X. D., Fukuda, N., Takakura, N. (2007) Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes. Stem Cells 25, 1326-33.
64. Stamm, C., Westphal, B., Kleine, H. D., et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-6.
65. Menasche, P., Hagege, A. A., Vilquin, J. T., et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41, 1078-83.
66. Reffelmann, T., Konemann, S., Kloner, R. A. (2009) Promise of blood- and bone marrowderived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 53, 305-8.
67. Dawn, B., Abdel-Latif, A., Sanganalmath, S. K., Flaherty, M. P., Zuba-Surma, E. K. (2009) Cardiac repair with adult bone marrowderived cells: the clinical evidence. Antioxid Redox Signal 11, 1865-82.
68. Hill, J. M., Zalos, G., Halcox, J. P., et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348, 593-600.
69. Werner, N., Kosiol, S., Schiegl, T., et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007.
70. Furfaro, E. M., Gaballa, M. A. (2007) Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol 5, 27-44.
71. Jaing, T. H., Hsia, S. H., Chiu, C. H., Hou, J. W., Wang, C. J., Chow, R. (2008) Successful unrelated cord blood transplantation in a girl with malignant infantile osteopetrosis. Chin Med J (Engl) 121, 1245-6.
72. Finney, M. R., Greco, N. J., Haynesworth, S. E., et al. (2006) Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol Blood Marrow Transplant 12, 585-93.
73. Prasad, A., Rihal, C. S., Lennon, R. J., Wiste, H. J., Singh, M., Holmes, D. R., Jr. (2007) Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol 49, 1611-8.
74. Stone, G. W., Gersh, B. J. (2006) Facilitated angioplasty: paradise lost. Lancet 367, 543-6.
75. Hochman, J. S., Lamas, G. A., Buller, C. E., et al. (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355, 2395-407.
76. Dale S. Adler, H. L., Ravi Nair, Jonathan L. Goldberg, Nicholas J. Greco, Tom Lassar, Daniel I. Simon, Mary J. Laughlin, and Vincent J. Pompili. (in press) Safety and efficacy of autologous intracoronary CD133+ stem cell injections in chronic total occlusions (SEACOAST trial). Cell Transplant.
77. Fredrickson, J. K. (1998) Umbilical cord blood stem cells: my body makes them, but do I get to keep them? Analysis of the FDA 52 Greco and Laughlin proposed regulations and the impact on individual constitutional property rights. J Contemp Health Law Policy 14, 477-502.
78. Nakahata, T., Ogawa, M. (1982) Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate monoand multipotential hemopoietic progenitors. J Clin Invest 70, 1324-8.
79. Broxmeyer, H. E., Douglas, G. W., Hangoc, G., et al. (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86, 3828-32.
80. Riordan, N. H., Chan, K., Marleau, A. M., Ichim, T. E. (2007) Cord blood in regenerative medicine: do we need immune suppression? J Transl Med 5, 8.
81. Storms, R. W., Trujillo, A. P., Springer, J. B., et al. (1999) Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A 96, 9118-23.